Mr. Capello is Executive Vice President and Chief Financial Officer of Biogen, and has served on the Executive Committee of the company since December 2017. Mr. Capello joined Biogen from Beacon Health Options, Inc., where he served as Executive Vice President and Chief Financial Officer. Mr. Capello was previously Chief Financial Officer of Ortho Clinical Diagnostics, Boston Scientific Corporation, and Perkin Elmer. His finance experience also includes the founding and running of his own company, Monomoy Advisors. Earlier in his career, Mr. Capello was a partner in the Boston and Amsterdam offices of PricewaterhouseCoopers. He was also a member of the Board of Directors of Sirtris Pharmaceuticals (acquired by GlaxoSmithKline), and served on its Audit Committee as both a member and its chair.
Mr. Capello is a certified public accountant. He holds a B.S. from the University of Vermont and an M.B.A. from Harvard Business School.